Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2001
12/27/2001WO2001098478A2 Clk-2, cex-7 and coq-4 genes, and uses thereof
12/27/2001WO2001098474A1 Biocatalyst inhibitors
12/27/2001WO2001098465A1 Cds1 GENE-KNOCKOUT CELLS AND MOUSE AND UTILIZATION THEREOF
12/27/2001WO2001098460A2 Fusion proteins of mycobacterium tuberculosis
12/27/2001WO2001098459A2 Hei-c encoding nucleic acids, polypeptides, antibodies and methods of use thereof
12/27/2001WO2001098456A2 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
12/27/2001WO2001098455A2 Method for preparing a physiologically active il-18 polypeptide
12/27/2001WO2001098454A2 Human dna sequences
12/27/2001WO2001098366A2 Enterokinase cleavage sequences and their use
12/27/2001WO2001098365A2 Peptide and polypeptide inhibitors of complement c1s
12/27/2001WO2001098364A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
12/27/2001WO2001098363A2 Peptides for use in the immunotherapy of renal cell carcinoma
12/27/2001WO2001098360A2 Gp354 nucleic acids and polypeptides
12/27/2001WO2001098356A1 Low oxygen affinity mutant hemoglobins
12/27/2001WO2001098355A2 Cgi-69 compositions and methods of use
12/27/2001WO2001098354A2 Human receptors
12/27/2001WO2001098353A2 Secreted proteins
12/27/2001WO2001098352A2 Thrombomodulin analogs for pharmaceutical use
12/27/2001WO2001098351A2 G-protein coupled receptors
12/27/2001WO2001098350A2 Compositions comprising net-4 modulations and their use for treating neoplastic disease
12/27/2001WO2001098349A2 Recombinant avidin monomer and its use in biotin binding
12/27/2001WO2001098348A2 Regulation of cellproliferation and differentiation using topically applied peptides
12/27/2001WO2001098347A1 Canine liver cell growth factor
12/27/2001WO2001098346A2 Methods and compositions for the treatment of peripheral artery disease
12/27/2001WO2001098345A1 Growth factors, nucleic acid encoding them and methods for identification
12/27/2001WO2001098344A2 Angiogenesis-modulating compositions and uses
12/27/2001WO2001098343A2 Conserved diaphanous-related formin autoregulatory domain (dad)
12/27/2001WO2001098342A1 Novel compounds
12/27/2001WO2001098341A1 Novel polypeptide and its dna
12/27/2001WO2001098339A2 Compositions and methods for the therapy and diagnosis of breast cancer
12/27/2001WO2001098338A2 Fluorescent proteins
12/27/2001WO2001098337A1 A novel polypeptide, a human uteroglobin 9 and the polynucleotide encoding the polypeptide
12/27/2001WO2001098336A1 A novel polypeptide, a human s4 ribosomal protein 10 and the polynucleotide encoding the polypeptide
12/27/2001WO2001098335A2 Transgenic algae for delivering antigens to an animal
12/27/2001WO2001098334A2 Streptococcus antigens
12/27/2001WO2001098333A2 Modification of hepatitis b core antigen
12/27/2001WO2001098332A2 Secreted redox proteins
12/27/2001WO2001098331A2 Glucagon-like peptide-1 analogs
12/27/2001WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS
12/27/2001WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001WO2001098323A2 G-protein coupled receptors
12/27/2001WO2001098319A1 A novel peptide---retinal binding site 12 and the polynucleotide coding this novel peptide
12/27/2001WO2001098318A1 Haplotypes of the slc26a2 gene
12/27/2001WO2001098314A2 Novel motor proteins and methods for their use
12/27/2001WO2001097861A2 Vitronectin receptor antagonist pharmaceuticals
12/27/2001WO2001097856A2 An orphan nuclear receptor
12/27/2001WO2001097844A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
12/27/2001WO2001097840A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
12/27/2001WO2001097839A1 Recombinant vaccines against infectious bursal disease virus
12/27/2001WO2001097837A1 Solubilised protein vaccines
12/27/2001WO2001097830A1 Modification of mdm2 activity
12/27/2001WO2001097827A1 Mhc peptides over-expressed on prostate cancer cells and methods of use
12/27/2001WO2001097785A2 Basic copolymers for the treatment of prion-related-disease
12/27/2001WO2001097608A2 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
12/27/2001WO2001079511A3 Hemolysin fusion proteins, their production and use
12/27/2001WO2001078894A9 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
12/27/2001WO2001070967A3 Regulation of human serotonin-like g protein-coupled receptor
12/27/2001WO2001070254A9 Use of human not1 and not1a orphan receptors
12/27/2001WO2001066243A3 Matrix reactor and a method for producing products in said reactor
12/27/2001WO2001066116A8 Method for modulating tumor growth and metastasis of tumor cells
12/27/2001WO2001059456A3 Compounds for detection of infection by chlamydophila abortus
12/27/2001WO2001055353A3 Recombinant attenuation of prrsv
12/27/2001WO2001055310A3 Nucleic acids, proteins, and antibodies
12/27/2001WO2001051516A3 Fusion proteins for stimulating cytotoxic t-cells
12/27/2001WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity
12/27/2001WO2001048186A3 Induction of defence genes in plants transformed with mybnt1
12/27/2001WO2001047549A3 Conjugate useful as building block for vaccine preparation
12/27/2001WO2001046256A3 Vesicle trafficking proteins
12/27/2001WO2001046214A3 Compound comprising a nucleic acid moiety and an organo-silane moiety
12/27/2001WO2001045738A3 Use of heat shock proteins to enhance production of chemokines by a cell
12/27/2001WO2001044438A3 Serological diagnostic method with rickettsia pulicis bacterium
12/27/2001WO2001044278A3 Antigen preparations
12/27/2001WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
12/27/2001WO2001038490A3 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA
12/27/2001WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof
12/27/2001WO2001034811A3 Bacillus thuringiensis hybrid toxins
12/27/2001WO2001032711A3 Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
12/27/2001WO2001031019A3 Neisserial antigenic peptides
12/27/2001WO2001030990A3 Isolated nucleic acid sequence conferring salt tolerance in rice plant
12/27/2001WO2001029215A3 N-cam homolog and splice variants thereof
12/27/2001WO2001025456A3 Method for production of proteinaceous substances
12/27/2001WO2001000803A3 Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
12/27/2001WO2001000014A3 Test animal for atherosclerosis model and methods for testing and screening
12/27/2001WO2000029448A3 Human proteins having hydrophobic domains and dnas encoding these proteins
12/27/2001US20010056180 Enzyme inhibitor; for the prevention of enzyme induced tissue damage; for treatment of respiratory disorders
12/27/2001US20010056179 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
12/27/2001US20010056118 Induction of polymerization of tubulin and the stabilization of microtubules in cells by administering to the cancer cells an effective amount of dictyostatin-1 or derivatives or salt
12/27/2001US20010056076 Treatment of acute lung injury and fibrosis with antagonists of alphavbeta6
12/27/2001US20010056075 Chimeric polypeptides of serum albumin and uses related thereto
12/27/2001US20010055791 Methods for enhancing the production of interferon in cell culture
12/27/2001US20010055790 Genetically engineered proteins for use in the treatment of cancer, cardiovascular, neurological and developmental disorders
12/27/2001US20010055789 Nucleotide sequences for use in the generation of amidated peptides
12/27/2001US20010055783 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore
12/27/2001US20010055782 Enzymatic protein for use in the diagnosis, treatment and prevention of alzheimer's disease and nervous system disorders
12/27/2001US20010055777 Potentiation of the immune response
12/27/2001US20010055767 Nucleotide sequences coding preferential polypeptides; for use as a diagnostic tool cellular analysis
12/27/2001US20010055759 Serotype-specific probes for listeria monocytogenes
12/27/2001US20010055758 Reagents and methods useful for detecting diseases of the prostate
12/27/2001US20010055756 Internal de novo initiation sites of the HCV NS5B polymerase and use thereof
12/27/2001US20010055751 PSCA: Prostate stem cell antigen and uses thereof
1 ... 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 ... 2916